i) The drug-protein interaction network
ii) The table result of interaction with CLPTM1L_Q96KA5
Protein Type Gene Name Drug Drug Source R FDR Cancer
CLPTM1L_Q96KA5 Canonical CLPTM1L 5-fluorouracil GDSC2:1073 -0.138 4.449e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L AZD7762 GDSC1:1022 0.171 1.080e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L Bayer IKKb inhibitor GDSC1:290 -0.201 2.165e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L BI-97C1 GDSC2:1849 0.141 3.935e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L bortezomib GDSC1:104 0.177 7.702e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L camptothecin GDSC1:1494 0.144 3.564e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L camptothecin GDSC2:1003 0.204 1.764e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L CGP-60474 GDSC1:53 0.192 3.570e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L CINK4 GDSC1:54 -0.149 2.826e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L cytarabine GDSC1:1006 0.136 4.858e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L cytarabine GDSC2:1006 0.16 1.801e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L ERK5-IN-1 GDSC1:106 -0.137 4.741e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L gemcitabine GDSC2:1190 0.153 2.465e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L GSK-2126458 GDSC1:283 0.241 1.693e-04 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L I-BET-762 GDSC1:275 -0.149 2.926e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L I-BET-762 GDSC2:1624 -0.172 1.008e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L kb NB 142-70 GDSC1:407 -0.21 1.285e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L KIN001-139 GDSC1:86 0.183 5.792e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L KIN001-173 GDSC1:224 -0.146 3.223e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L methotrexate GDSC1:1008 0.202 1.992e-03 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L mitoxantrone GDSC2:1810 0.149 2.823e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L MK-1775 GDSC2:1179 0.141 4.042e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L navitoclax GDSC1:1011 0.148 2.958e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L OSI-930 GDSC1:298 -0.135 4.971e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L oxaliplatin GDSC2:1089 -0.158 1.952e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L oxaliplatin GDSC2:1806 -0.218 7.697e-04 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L parthenolide GDSC1:89 -0.142 3.830e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L PF-00299804 GDSC1:363 0.144 3.580e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L PFI-1 GDSC1:1219 -0.141 3.920e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L S-trityl-L-cysteine GDSC1:41 0.136 4.917e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L SNX-2112 GDSC1:328 0.167 1.259e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L sorafenib GDSC2:1085 -0.136 4.877e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L teniposide GDSC2:1809 0.17 1.092e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L TL-1-85 GDSC1:261 -0.147 3.126e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L Torin 2 GDSC1:371 0.138 4.533e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L tozasertib GDSC1:32 0.171 1.064e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L tubastatin-A GDSC1:265 -0.162 1.594e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L venetoclax GDSC1:412 0.16 1.810e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L venetoclax GDSC2:1909 0.161 1.677e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L vinblastine GDSC2:1004 0.16 1.754e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L vinorelbine GDSC2:2048 0.139 4.380e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L Wee1 Inhibitor GDSC1:1046 -0.152 2.545e-02 ALL
CLPTM1L_Q96KA5 Canonical CLPTM1L WYE-125132 GDSC1:317 0.171 1.053e-02 ALL